RAPT Therapeutics, Inc. (RAPT) Other Working Capital Changes (2020 - 2024)
RAPT Therapeutics' Other Working Capital Changes history spans 5 years, with the latest figure at -$86000.0 for Q4 2024.
- For Q4 2024, Other Working Capital Changes fell 138.57% year-over-year to -$86000.0; the TTM value through Dec 2024 reached -$2.2 million, down 154.99%, while the annual FY2024 figure was -$2.2 million, 154.99% down from the prior year.
- Other Working Capital Changes for Q4 2024 was -$86000.0 at RAPT Therapeutics, up from -$712000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.1 million in Q1 2020 and bottomed at -$1.5 million in Q3 2020.
- The 5-year median for Other Working Capital Changes is -$543000.0 (2022), against an average of -$192315.8.
- The largest annual shift saw Other Working Capital Changes surged 298.21% in 2023 before it tumbled 410.92% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at -$1.3 million in 2020, then surged by 231.97% to $1.7 million in 2021, then plummeted by 96.72% to $56000.0 in 2022, then soared by 298.21% to $223000.0 in 2023, then tumbled by 138.57% to -$86000.0 in 2024.
- Per Business Quant, the three most recent readings for RAPT's Other Working Capital Changes are -$86000.0 (Q4 2024), -$712000.0 (Q3 2024), and -$712000.0 (Q2 2024).